4 completed, 1 recruiting, 1 terminated. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Milk Allergy: new trials by email Literature Review of Milk Allergy trials Research Report on Milk Allergy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Between a Rush and a Conventional Oral Immunotherapy Protocol to Treat Cow's Milk and Hen´s Egg Allergy. CompITO Study "Rush" regimen, "Conventional" regimen - Food Allergy in Children, Milk Allergy | Phase 2 / Phase 3 | Recruiting | Pablo Rodríguez del Rio | 40 | 2025-06-03 | 2026-02-18 |
| Impact of Infant Formula on Resolution of Cow's Milk Allergy Lactobacillus GG, Extensively Hydrolyzed Casein Formula, Amino Acid Formula - Milk Allergy | Phase 2 | Terminated | Massachusetts General Hospital | 49 | 2016-02-01 | 2018-07-13 |
| Milk Patch for Eosinophilic Esophagitis Viaskin Milk 500 mcg, Viaskin Placebo - Eosinophilic Esophagitis, Milk Allergy | Phase 2 | Completed | Children's Hospital of Philadelphia | 20 | 2015-10-01 | 2019-07-10 |
| OIT and Xolair® (Omalizumab) in Cow's Milk Allergy Placebo for omalizumab, Omalizumab, Milk powder - Milk Allergy | Phase 2 | Completed | Hugh A Sampson, MD | 77 | 2010-08-01 | 2020-08-14 |
| The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy Milk Protein Extract Immunotherapy goal of 4mg/day, Milk Protein Extract Immunotherapy goal of 7mg/day, Milk Powder Immunotherapy goal dose 2000 mg/day - Milk Allergy | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 30 | 2008-08-01 | 2017-05-15 |
| Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques). Procedure - Milk Allergy | Phase 1 / Phase 2 | Completed | Nambudripad's Allergy Research Foundation | 26 | 2005-01-01 | 2006-05-22 |
Milk Hypersensitivity (6) · Food Hypersensitivity (3) · Hypersensitivity (3) · Anaphylaxis (1) · Egg Hypersensitivity (1) · Eosinophilic Esophagitis (1)
Hypersensitivity, Immediate (6) · Immune System Diseases (6) · Food Hypersensitivity (3) · Hypersensitivity (3) · Digestive System Diseases (1) · Eosinophilia (1) · Esophageal Diseases (1) · Esophagitis (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukocyte Disorders (1)
Methods (1) · Omalizumab (1) · Refit milk powder (1)
Children's Hospital of Philadelphia (1) · Hugh A Sampson, MD (1) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · Nambudripad's Allergy Research Foundation (1) · Pablo Rodríguez del Rio (1)
United States (5) · Spain (1)
Antonella Cianferoni, MD, PhD (1) · Devi S Nambudripad, DC,PhD,L.Ac (1) · Hugh A. Sampson, M.D. (1) · Robert Wood, MD (1) · Wayne G Shreffler, MD, PhD (1)
PMID 25609353, PMID 26581915, PMID 31100455, PMID 33006765, PMID 41168926
U19AI044236 (1)